{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:25:39Z","timestamp":1792513539925,"version":"4.5.0"},"reference-count":30,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/or.2016.5212","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T10:49:16Z","timestamp":1478083756000},"page":"105-114","source":"Crossref","is-referenced-by-count":7,"title":["Upregulation of CD54 and downregulation of HLA-ABC contribute to the novel enhancement of the susceptibility of HL-60 cells to NK cell-mediated cytolysis induced by ATRA plus VPA"],"prefix":"10.3892","volume":"37","author":[{"given":"Huijuan","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianlian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,11,2]]},"reference":[{"key":"key20180107224900_b1-or-37-01-0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1535-6108(02)00081-8","article-title":"Focus on acute leukemias","volume":"1","author":"Gilliland","year":"2002","journal-title":"Cancer Cell"},{"key":"key20180107224900_b2-or-37-01-0105","first-page":"949","article-title":"All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia","volume":"100","author":"Huang","year":"1987","journal-title":"Report of 6 cases. Chin Med J"},{"key":"key20180107224900_b3-or-37-01-0105","first-page":"3345","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells","volume":"89","author":"Chen","year":"1997","journal-title":"Blood"},{"key":"key20180107224900_b4-or-37-01-0105","first-page":"3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II","volume":"89","author":"Shen","year":"1997","journal-title":"Clinical efficacy and pharmacokinetics in relapsed patients. Blood"},{"key":"key20180107224900_b5-or-37-01-0105","first-page":"S73","article-title":"Induction treatment of acute promyelocytic leukemia using all-trans retinoic acid. Controversies about dosage, advantages and side-effect management","volume":"8","author":"Dombret","year":"1994","journal-title":"Leukemia"},{"key":"key20180107224900_b6-or-37-01-0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s12185-013-1354-4","article-title":"Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia","volume":"97","author":"Tomita","year":"2013","journal-title":"Int J Hematol"},{"key":"key20180107224900_b7-or-37-01-0105","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.leu.2401508","article-title":"Histone deacetylase inhibitors are the potent inducer\/enhancer of differentiation in acute myeloid leukemia: A new approach to anti-leukemia therapy","volume":"13","author":"Kosugi","year":"1999","journal-title":"Leukemia"},{"key":"key20180107224900_b8-or-37-01-0105","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood-2003-12-4333","article-title":"Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid","volume":"104","author":"Kuendgen","year":"2004","journal-title":"Blood"},{"key":"key20180107224900_b9-or-37-01-0105","first-page":"986","article-title":"Valproic acid and all-trans retinoic acid for the treatment of elderly patients with acute myeloid leukemia","volume":"90","author":"Raffoux","year":"2005","journal-title":"Haematologica"},{"key":"key20180107224900_b10-or-37-01-0105","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1007\/s00277-005-0026-8","article-title":"Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia","volume":"84","author":"Kuendgen","year":"2005","journal-title":"Ann Hematol"},{"key":"key20180107224900_b11-or-37-01-0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.21552","article-title":"The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia","volume":"106","author":"Kuendgen","year":"2006","journal-title":"Cancer"},{"key":"key20180107224900_b12-or-37-01-0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1868-7083-5-12","article-title":"Histone deacetylase inhibition in the treatment of acute myeloid leukemia: The effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents","volume":"5","author":"Fredly","year":"2013","journal-title":"Clin Epigenetics"},{"key":"key20180107224900_b13-or-37-01-0105","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1182\/blood-2013-12-546283","article-title":"Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients","volume":"123","author":"Tassara","year":"2014","journal-title":"Blood"},{"key":"key20180107224900_b14-or-37-01-0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2011.12.041","article-title":"Valproic acid triggers differentiation and apoptosis in AML1\/ETO-positive leukemic cells specifically","volume":"319","author":"Zapotocky","year":"2012","journal-title":"Cancer Lett"},{"key":"key20180107224900_b15-or-37-01-0105","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/leu.2012.39","article-title":"Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL","volume":"26","author":"Leiva","year":"2012","journal-title":"Leukemia"},{"key":"key20180107224900_b16-or-37-01-0105","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3892\/ijo.2013.2236","article-title":"Enhancement of differentiation induction and upregulation of CCAAT\/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid","volume":"44","author":"Iriyama","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180107224900_b17-or-37-01-0105","doi-asserted-by":"crossref","first-page":"e98859","DOI":"10.1371\/journal.pone.0098859","article-title":"Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity","volume":"9","author":"Heo","year":"2014","journal-title":"PLoS One"},{"key":"key20180107224900_b18-or-37-01-0105","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-04-4252","article-title":"Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate","volume":"65","author":"Armeanu","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107224900_b19-or-37-01-0105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00262-008-0645-8","article-title":"Sodium butyrate upregulates expression of NKG2D ligand MICA\/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis","volume":"58","author":"Zhang","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107224900_b20-or-37-01-0105","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1349-7006.2009.01439.x","article-title":"Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell-mediated cytolysis","volume":"101","author":"Lu","year":"2010","journal-title":"Cancer Sci"},{"key":"key20180107224900_b21-or-37-01-0105","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/leu.2008.354","article-title":"Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate","volume":"23","author":"Poggi","year":"2009","journal-title":"Leukemia"},{"key":"key20180107224900_b22-or-37-01-0105","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107224900_b23-or-37-01-0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: Past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev"},{"key":"key20180107224900_b24-or-37-01-0105","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"key20180107224900_b25-or-37-01-0105","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1124\/jpet.106.118406","article-title":"Targeting AML1\/ETO-histone deacetylase repressor complex: A novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1\/ETO-positive acute myeloid leukemia cells","volume":"321","author":"Liu","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180107224900_b26-or-37-01-0105","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.leukres.2007.03.012","article-title":"Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia","volume":"31","author":"Cheng","year":"2007","journal-title":"Leuk Res"},{"key":"key20180107224900_b27-or-37-01-0105","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.leukres.2006.01.009","article-title":"Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells","volume":"30","author":"Deubzer","year":"2006","journal-title":"Leuk Res"},{"key":"key20180107224900_b28-or-37-01-0105","first-page":"283","article-title":"Growth inhibition and proapoptotic activity induction by IIF and valproic acid on RA-resistant leukemia cells","volume":"28","author":"Bartolini","year":"2008","journal-title":"Anticancer Res"},{"key":"key20180107224900_b29-or-37-01-0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4149\/neo_2010_05_438","article-title":"Neutrophilic differentiation modulates the apoptotic response of HL-60 cells to sodium butyrate and sodium valproate","volume":"57","author":"Vrba","year":"2010","journal-title":"Neoplasma"},{"key":"key20180107224900_b30-or-37-01-0105","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2007-07-101311","article-title":"NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities","volume":"111","author":"Diermayr","year":"2008","journal-title":"Blood"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.5212\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T23:02:46Z","timestamp":1515366166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.5212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,2]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/or.2016.5212"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.5212","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,2]]}}}